Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Burkitt Lymphoma 6Lymphoma, B-Cell 5Lymphoma 5Lymphoma, Large B-Cell, Diffuse 3Recurrence 2Lymphoma, Non-Hodgkin 2Hematologic Neoplasms 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Follicular 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1Leukemia 1Blast Crisis 1

Interventions

Vincristine 3pegaspargase 2merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2Methotrexate 2Dexamethasone 2Calcium Dobesilate 2venetoclax 1azathiopurine 1auricularum 1Vorinostat 1Thioguanine 1Spinal Puncture 1Specimen Handling 1Mitoxantrone 1Mercaptopurine 1Magnetic Resonance Spectroscopy 1Leucovorin 1Inotuzumab Ozogamicin 1Doxorubicin 1Decitabine 1Cytarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Inotuzumab Ozogamicin × Clear all
NCT03677596 2023-11-22

A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients

Pfizer

Phase 4 Completed
102 enrolled 27 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡